Disclaimer
is pocket card is derived om recommendations in the American Society of Clinical Oncology
Guideline. is resource is a practice tool based on ASCO
®
practice guidelines and is not intended to
substitute for the independent professional judgment of the treating physician. Practice guidelines do
not account for individual variation among patients. is pocket card does not purport to suggest any
particular course of medical treatment. Use of the practice guidelines and this resource are voluntary.
e practice guidelines and additional information are available at www.asco.org/cardiac-guideline.
Copyright © 2016 by American Society of Clinical Oncology. All rights reserved.
Source
Armenian SH et al. Prevention and Monitoring of Cardiac Dysfunction in Survivors of
Adult Cancers: American Society of Clinical Oncolog y Clinical Practice Guideline.
2016 Dec 5: JCO2016705400. [Epub ahead of print]
Abbreviations
HF, heart failure; MRI, magnetic resonance imaging ; MUGA, multi-gated acquisition
106 Commerce Street, Suite 105
Lake Mary, FL 32746
TEL: 407.878.7606 • FAX: 407.878.7611
For additional copies, order at GuidelineCentral.com
Copyright © 2016 All rights reserved
ASCOCAR6112
Recommendation Grading
Type Benefit/harm Evidence Quality
Strength Of
Recommendation
EB Evidence-
based
B Benefits
outweigh harms
H High Strong
CB
Consensus-
based
H Harms outweigh
benefits
I Intermediate Moderate
IC Informal
consensus
B/H Relative balance
of benefits and
harms
L Low Weak
Ins Insufficient
ASCO believes that cancer clinical trials are vital to inform medical decisions and
improve cancer care and that all patients should have the opportunity to participate.
Additional information, which may include data supplements, slide sets, patient
versions, frequently asked questions, and other clinical tools and resources, is available at
www.asco.org/cardiac-guideline and www.asco.org/guidelineswiki
